Bio-Techne (TECH) Land & Improvements (2010 - 2016)
Bio-Techne's quarterly Land & Improvements came in at $6.3 million in Q2 2016, down 14.93% year-on-year from $7.4 million in Q3 2015, and down 14.93% quarter-over-quarter from $7.4 million in Q2 2015.
Bio-Techne has reported Land & Improvements for 7 years, with the latest figure at $6.3 million in Q2 2016.
- For the quarter ending Q2 2016, Land & Improvements fell 14.93% year-over-year to $6.3 million; the trailing twelve-month figure through Jun 2016 stood at $6.3 million (down 14.93% YoY), and the FY2016 full-year result was $6.3 million, down 14.93% from the prior year.
- Land & Improvements for Q2 2016 stood at $6.3 million, down from $7.4 million in the prior quarter.
- The five-year high for Land & Improvements was $7.5 million in Q4 2012, with the low at $6.3 million in Q2 2016.
- Average Land & Improvements over 5 years is $7.4 million, with a median of $7.4 million recorded in 2013.
- Year-over-year, Land & Improvements gained 0.67% in 2012 and decreased 14.93% in 2016.
- Tracing TECH's Land & Improvements over 5 years: stood at $7.5 million in 2012, then decreased by 1.09% to $7.4 million in 2013, then declined by 0.32% to $7.4 million in 2014, then dropped by 0.47% to $7.4 million in 2015, then declined by 14.93% to $6.3 million in 2016.
- The last three Land & Improvements figures came in at $6.3 million (Q2 2016), $7.4 million (Q2 2015), and $7.4 million (Q3 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 6.27 Mn |
| Jun 30, 2015 | 7.37 Mn |
| Sep 30, 2014 | 7.41 Mn |
| Jun 30, 2014 | 7.47 Mn |
| Mar 31, 2014 | 7.44 Mn |
| Dec 31, 2013 | 7.43 Mn |
| Sep 30, 2013 | 7.51 Mn |
| Jun 30, 2013 | 7.44 Mn |
| Mar 31, 2013 | 7.44 Mn |
| Dec 31, 2012 | 7.51 Mn |
| Sep 30, 2012 | 7.51 Mn |
| Jun 30, 2012 | 7.47 Mn |
| Mar 31, 2012 | 7.49 Mn |
| Dec 31, 2011 | 7.46 Mn |
| Sep 30, 2011 | 7.46 Mn |
| Jun 30, 2011 | 7.50 Mn |
| Jun 30, 2010 | 7.42 Mn |